Annual EBIT
$250.80 M
+$205.00 M+447.60%
31 December 2023
Summary:
Insulet annual earnings before interest & taxes is currently $250.80 million, with the most recent change of +$205.00 million (+447.60%) on 31 December 2023. During the last 3 years, it has risen by +$168.60 million (+205.11%). PODD annual EBIT is now at all-time high.PODD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$95.20 M
+$33.10 M+53.30%
30 September 2024
Summary:
Insulet quarterly earnings before interest & taxes is currently $95.20 million, with the most recent change of +$33.10 million (+53.30%) on 30 September 2024. Over the past year, it has dropped by -$19.30 million (-16.86%). PODD quarterly EBIT is now -16.86% below its all-time high of $114.50 million, reached on 31 December 2023.PODD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$337.40 M
+$31.10 M+10.15%
30 September 2024
Summary:
Insulet TTM earnings before interest & taxes is currently $337.40 million, with the most recent change of +$31.10 million (+10.15%) on 30 September 2024. Over the past year, it has increased by +$86.60 million (+34.53%). PODD TTM EBIT is now at all-time high.PODD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PODD EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -16.9% | +34.5% |
| 3 y3 years | +205.1% | +85.9% | +310.5% |
| 5 y5 years | +441.7% | +460.0% | +628.7% |
PODD EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +447.6% | -16.9% | +440.0% | at high | +733.1% |
| 5 y | 5 years | at high | +447.6% | -16.9% | +440.0% | at high | +1733.7% |
| alltime | all time | at high | +409.0% | -16.9% | +440.0% | at high | +515.7% |
Insulet EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $95.20 M(+53.3%) | $337.40 M(+10.2%) |
| June 2024 | - | $62.10 M(-5.3%) | $306.30 M(+8.5%) |
| Mar 2024 | - | $65.60 M(-42.7%) | $282.40 M(+12.6%) |
| Dec 2023 | $250.80 M(+447.6%) | $114.50 M(+78.6%) | $250.80 M(+49.9%) |
| Sept 2023 | - | $64.10 M(+67.8%) | $167.30 M(+56.8%) |
| June 2023 | - | $38.20 M(+12.4%) | $106.70 M(+163.5%) |
| Mar 2023 | - | $34.00 M(+9.7%) | $40.50 M(-7.3%) |
| Dec 2022 | $45.80 M(-44.3%) | $31.00 M(+785.7%) | $43.70 M(-31.6%) |
| Sept 2022 | - | $3.50 M(-112.5%) | $63.90 M(-29.9%) |
| June 2022 | - | -$28.00 M(-175.3%) | $91.10 M(-14.3%) |
| Mar 2022 | - | $37.20 M(-27.3%) | $106.30 M(+29.3%) |
| Dec 2021 | $82.20 M(+49.7%) | $51.20 M(+66.8%) | $82.20 M(+235.5%) |
| Sept 2021 | - | $30.70 M(-339.8%) | $24.50 M(+33.2%) |
| June 2021 | - | -$12.80 M(-197.7%) | $18.40 M(-69.2%) |
| Mar 2021 | - | $13.10 M(-301.5%) | $59.70 M(+8.7%) |
| Dec 2020 | $54.90 M(+18.6%) | -$6.50 M(-126.4%) | $54.90 M(-30.0%) |
| Sept 2020 | - | $24.60 M(-13.7%) | $78.40 M(+23.3%) |
| June 2020 | - | $28.50 M(+243.4%) | $63.60 M(+44.5%) |
| Mar 2020 | - | $8.30 M(-51.2%) | $44.00 M(-5.0%) |
| Dec 2019 | $46.30 M(+47.0%) | $17.00 M(+73.5%) | $46.30 M(-0.1%) |
| Sept 2019 | - | $9.80 M(+10.1%) | $46.37 M(+4.0%) |
| June 2019 | - | $8.90 M(-16.0%) | $44.61 M(+8.6%) |
| Mar 2019 | - | $10.60 M(-37.9%) | $41.07 M(+27.7%) |
| Dec 2018 | $31.50 M(-520.0%) | $17.07 M(+112.3%) | $32.15 M(+152.7%) |
| Sept 2018 | - | $8.04 M(+49.9%) | $12.72 M(+74.6%) |
| June 2018 | - | $5.36 M(+218.8%) | $7.29 M(-872.1%) |
| Mar 2018 | - | $1.68 M(-171.3%) | -$944.00 K(-87.4%) |
| Dec 2017 | -$7.50 M(-39.7%) | -$2.36 M(-190.6%) | -$7.50 M(-16.3%) |
| Sept 2017 | - | $2.60 M(-190.7%) | -$8.96 M(-22.0%) |
| June 2017 | - | -$2.87 M(-41.1%) | -$11.49 M(+17.5%) |
| Mar 2017 | - | -$4.87 M(+27.6%) | -$9.78 M(-21.4%) |
| Dec 2016 | -$12.43 M(-74.5%) | -$3.82 M(-4997.4%) | -$12.43 M(-41.5%) |
| Sept 2016 | - | $78.00 K(-106.7%) | -$21.24 M(-41.1%) |
| June 2016 | - | -$1.16 M(-84.6%) | -$36.10 M(-26.3%) |
| Mar 2016 | - | -$7.53 M(-40.4%) | -$48.97 M(+0.6%) |
| Dec 2015 | -$48.68 M(+46.2%) | -$12.63 M(-14.5%) | -$48.68 M(+39.5%) |
| Sept 2015 | - | -$14.77 M(+5.3%) | -$34.89 M(+25.1%) |
| June 2015 | - | -$14.03 M(+93.8%) | -$27.90 M(-28.4%) |
| Mar 2015 | - | -$7.24 M(-727.8%) | -$38.95 M(+17.0%) |
| Dec 2014 | -$33.30 M | $1.15 M(-114.8%) | -$33.30 M(+1.3%) |
| Sept 2014 | - | -$7.78 M(-69.0%) | -$32.87 M(-22.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$25.08 M(+1477.6%) | -$42.37 M(+81.1%) |
| Mar 2014 | - | -$1.59 M(-200.0%) | -$23.40 M(-16.4%) |
| Dec 2013 | -$27.98 M(-22.0%) | $1.59 M(-109.2%) | -$27.98 M(-21.5%) |
| Sept 2013 | - | -$17.29 M(+182.9%) | -$35.63 M(+33.0%) |
| June 2013 | - | -$6.11 M(-1.1%) | -$26.79 M(-14.1%) |
| Mar 2013 | - | -$6.18 M(+2.0%) | -$31.17 M(-13.1%) |
| Dec 2012 | -$35.86 M(-15.3%) | -$6.06 M(-28.2%) | -$35.86 M(-11.0%) |
| Sept 2012 | - | -$8.44 M(-19.6%) | -$40.28 M(-3.1%) |
| June 2012 | - | -$10.49 M(-3.4%) | -$41.58 M(-9.5%) |
| Mar 2012 | - | -$10.87 M(+3.7%) | -$45.96 M(+8.6%) |
| Dec 2011 | -$42.33 M(+10.0%) | -$10.48 M(+7.6%) | -$42.33 M(+2.2%) |
| Sept 2011 | - | -$9.74 M(-34.5%) | -$41.41 M(+3.7%) |
| June 2011 | - | -$14.88 M(+105.6%) | -$39.95 M(+14.2%) |
| Mar 2011 | - | -$7.24 M(-24.3%) | -$34.97 M(-9.1%) |
| Dec 2010 | -$38.47 M(-34.9%) | -$9.56 M(+15.5%) | -$38.47 M(-5.3%) |
| Sept 2010 | - | -$8.28 M(-16.4%) | -$40.63 M(-11.4%) |
| June 2010 | - | -$9.90 M(-7.7%) | -$45.83 M(-12.5%) |
| Mar 2010 | - | -$10.73 M(-8.5%) | -$52.38 M(-11.4%) |
| Dec 2009 | -$59.12 M(-27.2%) | -$11.72 M(-13.0%) | -$59.12 M(-11.2%) |
| Sept 2009 | - | -$13.48 M(-18.0%) | -$66.58 M(-8.7%) |
| June 2009 | - | -$16.45 M(-5.9%) | -$72.94 M(-7.2%) |
| Mar 2009 | - | -$17.47 M(-8.9%) | -$78.63 M(-3.1%) |
| Dec 2008 | -$81.17 M(+50.8%) | -$19.19 M(-3.3%) | -$81.17 M(+4.0%) |
| Sept 2008 | - | -$19.83 M(-10.4%) | -$78.04 M(+7.2%) |
| June 2008 | - | -$22.14 M(+10.6%) | -$72.79 M(+15.4%) |
| Mar 2008 | - | -$20.01 M(+24.7%) | -$63.06 M(+17.1%) |
| Dec 2007 | -$53.84 M(+55.4%) | -$16.05 M(+10.1%) | -$53.84 M(+14.6%) |
| Sept 2007 | - | -$14.58 M(+17.5%) | -$46.99 M(+12.0%) |
| June 2007 | - | -$12.41 M(+14.9%) | -$41.94 M(+45.3%) |
| Mar 2007 | - | -$10.80 M(+17.4%) | -$28.86 M(+66.0%) |
| Dec 2006 | -$34.65 M(+61.1%) | -$9.20 M(-3.5%) | -$17.38 M(+18.3%) |
| Sept 2006 | - | -$9.53 M(-1514.4%) | -$14.70 M(+44.0%) |
| June 2006 | - | $674.00 K(0.0%) | -$10.21 M(-35.9%) |
| Mar 2006 | - | $674.00 K(-110.3%) | -$15.92 M(-26.4%) |
| Dec 2005 | -$21.50 M(+51.9%) | -$6.51 M(+29.2%) | -$21.64 M(+43.1%) |
| Sept 2005 | - | -$5.04 M(0.0%) | -$15.12 M(+50.0%) |
| June 2005 | - | -$5.04 M(0.0%) | -$10.08 M(+100.0%) |
| Mar 2005 | - | -$5.04 M | -$5.04 M |
| Dec 2004 | -$14.15 M(+17.8%) | - | - |
| Dec 2003 | -$12.01 M(-5.2%) | - | - |
| Dec 2002 | -$12.67 M | - | - |
FAQ
- What is Insulet annual earnings before interest & taxes?
- What is the all time high annual EBIT for Insulet?
- What is Insulet quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Insulet?
- What is Insulet quarterly EBIT year-on-year change?
- What is Insulet TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Insulet?
- What is Insulet TTM EBIT year-on-year change?
What is Insulet annual earnings before interest & taxes?
The current annual EBIT of PODD is $250.80 M
What is the all time high annual EBIT for Insulet?
Insulet all-time high annual earnings before interest & taxes is $323.60 M
What is Insulet quarterly earnings before interest & taxes?
The current quarterly EBIT of PODD is $95.20 M
What is the all time high quarterly EBIT for Insulet?
Insulet all-time high quarterly earnings before interest & taxes is $114.50 M
What is Insulet quarterly EBIT year-on-year change?
Over the past year, PODD quarterly earnings before interest & taxes has changed by -$19.30 M (-16.86%)
What is Insulet TTM earnings before interest & taxes?
The current TTM EBIT of PODD is $337.40 M
What is the all time high TTM EBIT for Insulet?
Insulet all-time high TTM earnings before interest & taxes is $337.40 M
What is Insulet TTM EBIT year-on-year change?
Over the past year, PODD TTM earnings before interest & taxes has changed by +$86.60 M (+34.53%)